Enhancement of P2X7-induced pore formation and apoptosis: An early effect of diabetes on the retinal microvasculature

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 3, 2004, Pages 1026-1032

  Sugiyama, Tetsuya ^a   Kobayshi, Masato ^a   Kawamura, Hajime ^a   Li, Qing ^a   Puro, Donald G ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 3; DYE; IODINE DERIVATIVE; PURINE P2X7 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; TRYPAN BLUE; UNCLASSIFIED DRUG; YO PRO 1; 3' O (4 BENZOYL)BENZOYLADENOSINE 5' TRIPHOSPHATE; 3'-O-(4-BENZOYL)BENZOYLADENOSINE 5'-TRIPHOSPHATE; BENZOXAZOLE DERIVATIVE; DRUG DERIVATIVE; FLUORESCENT DYE; ION CHANNEL; PURINE P2 RECEPTOR; QUINOLINE DERIVATIVE; YO-PRO 1;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL NUCLEUS; CELL VIABILITY; CHANNEL GATING; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; ELECTROPHYSIOLOGY; HYPERGLYCEMIA; IMMUNOREACTIVITY; ION CURRENT; MEMBRANE CHANNEL; MEMBRANE PORE; NICK END LABELING; NONHUMAN; PATCH CLAMP; PERICYTE; PRIORITY JOURNAL; RAT; RETINA CAPILLARY; STREPTOZOCIN DIABETES; ANIMAL; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; DRUG EFFECT; ENZYME IMMUNOASSAY; EXPERIMENTAL DIABETES MELLITUS; LONG EVANS RAT; METABOLISM; PATHOLOGY; RETINA BLOOD VESSEL; VASCULAR ENDOTHELIUM;

ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS; BENZOXAZOLES; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ELECTROPHYSIOLOGY; ENDOTHELIUM, VASCULAR; FLUORESCENT DYES; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; ION CHANNELS; PERICYTES; QUINOLINIUM COMPOUNDS; RATS; RATS, LONG-EVANS; RECEPTORS, PURINERGIC P2; RETINAL VESSELS;

EID: 1542531909     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-1062     Document Type: Article

References (32)

1. Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest. 1996;97:2883-2890.
2. Shepro D, Morel NM. Pericyte physiology. FASEB J. 1993;7:1031-1038.
3. Enge M, Bjarnegard M, Gerhardt H, et al. Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J. 2002;21:4307-4316.
4. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol. 2000;130:963-974.
5. Cai J, Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye 2002;16:242-260.
6. Archer DB. Bowman Lecture 1998. Diabetic retinopathy: some cellular, molecular and therapeutic considerations. Eye 1999;13: 497-523.
7. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820.
8. Kawamura H, Sugiyama T, Wu DM, et al. ATP: a vasoactive signal in the pericyte-containing microvasculature of the rat retina. J Physiol. 2003;551:787-799.
9. Cockcroft S, Gomperts BD. ATP induces nucleotide permeability in rat mast cells. Nature. 1979;279:541-542.
10. Harada H, Chan CM, Loesch A, Unwin R, Burnstock G. Induction of proliferation and apoptotic cell death via P2Y and P2X receptors, respectively, in rat glomerular mesangial cells. Kidney Int. 2000;57:949-958.
11. 7 receptor-dependent apoptosis of dendritic cells. Am J Physiol. 1999;276:C1139-C1147.
12. 7). Science. 1996;272:735-738.
13. Sakagami K, Wu DM, Puro DG. Physiology of rat retinal pericytes: modulation of ion channel activity by serum-derived molecules. J Physiol. 1999;521:637-650.
14. + currents in rat retinal pericytes. Vis Neurosci. 2001; 18:935-940.
15. Kodama T, Oku H, Kawamura H, Sakagami K, Puro DG. Platelet-derived growth factor-BB: a survival factor for the retinal microvasculature during periods of metabolic compromise. Curr Eye Res. 2001;23:93-97.
16. Kuwabara T, Cogan D. Studies of retinal vascular patterns. 1: normal architecture. Arch Ophthalmol. 1960;64:904-911.
17. Barry PH. JPCalc, a software package for calculating liquid junction potential corrections in patch-clamp, intracellular, epithelial and bilayer measurements and for correcting junction potential measurements. J Neurosci Methods 1994;51:107-116.
18. North RA, Surprenant A. Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol. 2000;40:563-580.
19. Gudipaty L, Humphreys BD, Buell G, Dubyak GR. Regulation of P2X(7) nucleotide receptor function in human monocytes by extracellular ions and receptor density. Am J Physiol. 2001;280: C943-C953.
20. Michel AD, Chessell IP, Humphrey PP. Ionic effects on human recombinant P2X7 receptor function. Naunyn Schmiedebergs Arch Pharmacol. 1999;359:102-109.
21. Solini A, Chiozzi P, Falzoni S, Morelli A, Fellin R, Di Virgilio F. High glucose modulates P2X7 receptor-mediated function in human primary fibroblasts. Diabetologia. 2000;43:1248-1256.
22. 7 receptors. Am J Physiol. 2002;283:C77-C84.
23. 7 receptor currents in Muller glial cells during proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2001;42:860-867.
24. North RA. Molecular physiology of P2X receptors. Physiol Rev. 2002;82:1013-1067.
25. 7 receptor. J Physiol. 1999;519:335-346.
26. 7-transfected HEK293 cells. Mol Biol Cell. 2003;14:2655-2664.
27. Zanovello P, Bronte V, Rosato A, Pizzo P, Di Virgilio F. Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmemation. J Immunol. 1990;145:1545-1550.
28. Boeri D, Maiello M, Lorenzi M. Increased prevalence of microthrombi in retinal capillaries of diabetic individuals. Diabetes. 2001;50:1432-1439.
29. Brandle U, Guenther E, Irrle C, Wheeler-Schilling TH. Gene expression of the P2X receptors in the rat retina. Brain Res Mol Brain Res. 1998;59:269-272.
30. 7 receptors in Müller glial cells from the human retina. J Neurosci. 2000;20:5965-5972.
31. 7 containing purinergic receptors in Müller cells of the rat retina. Brain Res Mol Brain Res. 2000;76:205-210.
32. 7 receptors. Br J Pharmacol. 2000;130:167-173.